Clinical Trials

Phase 3 Study of Ibrutinib in Combination with Venetoclax in Subjects with Mantle Cell Lymphoma


Study ID
Pharmacyclics PCYC-1143-CA

NCT Number
NCT03112174 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0235

Principle Investigator
Dr. Andre Goy

Phase
III

Sponsor
Pharmacyclics


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now